Showing 1-5 of 26 news & articles:
NEW PROJECT PUTS STANDARDIZED OUTCOMES MEASURES FOR DEPRESSION INTO REAL-WORLD USE, FROM REGISTRIES TO THE CLINIC

New Project Puts Standardized Outcomes Measures for Depression into Real-World Use, from Registries to the Clinic  OM1 partners with AHRQ, ABFM, APA and others to implement  BOSTON, July 17, 2019 —OM1, a leading health outcomes and technology company, today announced it is has been awarded the CAPSTONE – Outcome Measure Harmonization and Data Infrastructure for[…]

BHE & OM1 PARTNER TO DELIVER RHEUMATOLOGY REGISTRIES THROUGH IHD

Research-Grade, Analytic-Ready Rheumatology Data at Your Fingertips through the IHD Platform What would you do with rapid access to analytics and insights from hundreds of thousands of rheumatology patients? Bringing together the largest linked, longitudinal rheumatology condition registries with the industry-leading Instant Health Data (IHD) platform, OM1 and BHE join forces to deliver a powerful[…]

OM1 RHEUMATOID ARTHRITIS REGISTRY REACHES MORE THAN 100,000 PATIENTS PROSPECTIVELY FOLLOWED WITH DEEP CLINICAL DATA

BOSTON, January 16, 2019 — OM1, a leading health outcomes, registries and technology company creating solutions to better understand, compare, and predict patient outcomes, today announced that its Rheumatoid Arthritis (RA) registry has reached more than 100,000 patients with deep clinical data and is available for licensing, studies and advanced analytics. RA is a chronic autoimmune[…]

OM1 NAMED ONE OF THE MOST INNOVATIVE STARTUPS OF 2018 BY PM360

December 18, 2018 – PM360, a leading trade magazine for marketing decision makers in the pharmaceutical, biotech, medical device, and diagnostics industries, has named OM1 as one of the most innovative Services of 2018. Founded in 2015, OM1 is a health outcomes and technology company leveraging big clinical data, standardized outcome measurement, and artificial intelligence[…]

1 2 3 6